LAMEA Digital Therapeutics Market By End Use (Patients, Providers, Payers, Employers and Others), By Applications (Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Digital Therapeutics Market
Market Report Description
The Latin America, Middle East and Africa Digital Therapeutics Market would witness market growth of 22.8% CAGR during the forecast period (2021-2027). There is an increasing demand for digital therapeutics across the globe, due to the rising adoption of smartphones & tablets along with healthcare apps, increasing cases of chronic diseases, and the growing need to manage healthcare costs.
Moreover, high growth opportunities in the undiscovered markets are anticipated to offer new growth avenues for the manufacturers operating in the digital therapeutics market. Though, the absence of awareness related to digital therapeutics in emerging nations and the increasing concern about patient data is hampering the growth of the market. There is a rising awareness among the general public due to the consistently evolving digital landscape.
Moreover, factors like increasing cases of chronic diseases across the world and the increasing technological developments are also contributing to the growth of the market. With the rising awareness among end-users due to the adoption of various digital gadgets and solutions, the demand for digital therapeutics is anticipated to surge the market growth in the coming years. It is expected that people will maintain this inclination towards digital health space, which will spur the demand for customized, more engaging, and accessible medical solutions. Consumers are increasingly using smartphones and the internet that also acts as a major factor contributing to the growth of the market.
The Patients market dominated the UAE Digital Therapeutics Market by End Use 2020, thereby, achieving a market value of $64.1 million by 2027, growing at a CAGR of 20.8 % during the forecast period. The Providers market is experiencing a CAGR of 21.7% during (2021 - 2027). Additionally, The Payers market is expected to witness highest CAGR of 22.9% during (2021 - 2027).
Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- ResMed, Inc. (Propeller Health)
- Teladoc Health, Inc. (Livongo Health)
- Noom, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Canary Health
- Mango Health, Inc. (TrialCard, Incorporated)
- 2Morrow, Inc.
- Pear Therapeutics, Inc.
- Mindstrong, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free